QUOTE AND NEWS
Market Intelligence Center  May 15  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Tuesday's trading session at $59.00. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $57.85...
StreetInsider.com  May 7  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/Jazz+Pharmaceuticals%2C+Inc.+%28JAZZ%29+Tops+Q1+EPS+by+2c%3B+Guides+Above+the+Street/8313708.html for the full story.
Market Intelligence Center  Apr 11  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Wednesday's trading session at $54.73. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $54.18...
Market Intelligence Center  Apr 5  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Thursday's trading session at $55.03. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $53.66...
Market Intelligence Center  Apr 1  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Thursday's trading session at $55.91. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $55.04...
Market Intelligence Center  Mar 19  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Monday's trading session at $58.75. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $57.96...
Market Intelligence Center  Mar 13  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Tuesday's trading session at $59.42. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.79. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $58.09...
TheStreet.com  Mar 11  Comment 
NEW YORK (TheStreet) -- CHANGE IN RATINGS Aspen Insurance was upgraded at Credit Suisse to outperform from neutral. Restructuring initiatives will lead to increased earnings power, Credit Suisse said. Earnings estimates increased through...
Market Intelligence Center  Mar 7  Comment 
Jazz Pharmaceuticals Inc. (NASDAQ: JAZZ) closed Wednesday's trading session at $59.12. In the past year, the stock has hit a 52-week low of $40.38 and 52-week high of $60.25. Jazz Pharmaceuticals (JAZZ) stock has been showing support around $58.30...
StreetInsider.com  Mar 5  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Jazz+Pharma+%28JAZZ%29+Prices+5.38M+Secondary+Offering/8156052.html for the full story.





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki